Winton Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
+35,800
New +$1.01M 0.03% 509
2020
Q2
– Sell
-21,743
Closed -$730K – 1444
2020
Q1
$730K Sell
21,743
-271
-1% -$9.74K 0.02% 910
2019
Q4
$716K Buy
+22,014
New +$626K 0.01% 1143
2019
Q2
– Sell
-9,083
Closed -$243K – 1123
2019
Q1
$243K Buy
+9,083
New +$276K ﹤0.01% 886

Other funds holding ATRC

Winton Group's ATRC Position: Q2 2026 in Review

Winton Group opened a new position in AtriCure (ATRC) in Q2 2026: 35,800 shares worth $1M. The stake represents 0.03% of the portfolio and ranks #509 among its holdings. This is a return to the name: Winton Group previously reported a position in ATRC as recently as Q1 2020.

Winton Group first reported a position in ATRC in Q1 2019 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Winton Group held 35,800 shares of AtriCure worth $1M as of Q2 2026.
  • AtriCure was a new Winton Group position in Q2 2026.
  • AtriCure made up 0.03% of Winton Group's portfolio in Q2 2026, its #509 holding.
  • Winton Group first reported a position in AtriCure in Q1 2019 and has held it in 4 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.